Suchergebnisse
Suchergebnisse:
Bert Vogelstein (* 2. Juni 1949 in Baltimore, Maryland, USA) ist ein US-amerikanischer Krebsforscher an der Johns-Hopkins-Universität in Baltimore, Maryland, USA. Bert Vogelstein erlangte seinen Bachelor-Abschluss 1970 an der University of Pennsylvania und seinen Medical Doctor 1974 an der Johns Hopkins University.
Bert Vogelstein (born 1949) is director of the Ludwig Center, Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at The Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center.
- Breakthrough Prize in Life Sciences (2013), Warren Triennial Prize (2014)
- p53, Vogelgram, somatic evolution in cancer
2. Mai 2024 · Notable Works: “The Genetics of Cancer”. Subjects Of Study: APC. cancer. dicyclohexylcarbodiimide. genetics. p53. Bert Vogelstein (born June 2, 1949, Baltimore, Md., U.S.) is an American oncologist known for his groundbreaking work on the genetics of cancer.
- The Editors of Encyclopaedia Britannica
Bert Vogelstein is a co-director of the Ludwig Center at Johns Hopkins and a pioneer of cancer genomics. He studies the genetic causes and prevention of cancer using digital PCR and liquid biopsies.
Dr. Vogelstein is a cancer researcher and co-director of the Ludwig Center at Johns Hopkins University. He studies the molecular genetics of human cancer and develops new prevention and treatment strategies based on cancer driver genes.
5468. 1998. Participation of p53 protein in the cellular response to DNA damage. MB Kastan, O Onyekwere, D Sidransky, B Vogelstein, RW Craig. Cancer research 51 (23_Part_1), 6304-6311. , 1991. 5327. 1991. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC.
17. Dez. 2021 · Learn about the life and achievements of Bert Vogelstein, M.D., the co-director of the Ludwig Center at Johns Hopkins Kimmel Cancer Center and a Howard Hughes Medical Institute investigator. He is best known for his landmark work in deciphering and explaining the molecular genetic basis of cancer.
